Back to BARCLAYS PLC BARCLAYS PLC

CTXRCTXR
3 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in CITIUS PHARMACEUTICALS INC

Yes. Barclays holds 1,096 shares of CTXR (Citius Pharmaceuticals), worth $663, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$663

Current Shares

1,096

Total Value Change

+$620

Total Shares Change

+1,067

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1,096
-
$6630.0%$0.61
17
2025-Q2
Exited
0
-100.0%
$00.0%$1.59
0
2025-Q1
New
29
-
$430.0%$1.49
17

Other major holders of CTXR: VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used